Kate T. Murphy
Melbourne, VIC 3010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia.
Journal: Life sciences
Published: October 24, 2024
Orphan GPCR GPRC5C Facilitates Angiotensin II-Induced Smooth Muscle Contraction.
Journal: Circulation research
Published: April 10, 2024
Sulforaphane attenuates cancer cell-induced atrophy of C2C12 myotubes.
Journal: American journal of physiology. Cell physiology
Published: December 19, 2022
Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments.
Journal: Journal of cachexia, sarcopenia and muscle
Published: September 16, 2022
Role for Plant-Derived Antioxidants in Attenuating Cancer Cachexia.
Journal: Antioxidants (Basel, Switzerland)
Published: December 07, 2021
Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophy.
Journal: American journal of physiology. Cell physiology
Published: March 17, 2021
Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer.
Journal: Cancer research
Published: April 19, 2018
Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle.
Journal: Molecular metabolism
Published: July 29, 2016
BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
Journal: The American journal of pathology
Published: February 10, 2016
The pathogenesis and treatment of cardiac atrophy in cancer cachexia.
Journal: American journal of physiology. Heart and circulatory physiology
Published: September 14, 2015
Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.
Journal: Science translational medicine
Published: May 04, 2015
Last Updated: 09/26/2026